Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Commentary: tioguanine in the treatment of refractory coeliac disease.

Mooney PD, Sanders DS, Hadjivassilou M, Lennard L.

Aliment Pharmacol Ther. 2012 Sep;36(6):594-5; author reply 595. doi: 10.1111/j.1365-2036.2012.05210.x. No abstract available.

2.

Tioguanine in the treatment of refractory coeliac disease--a single centre experience.

Tack GJ, van Asseldonk DP, van Wanrooij RL, van Bodegraven AA, Mulder CJ.

Aliment Pharmacol Ther. 2012 Aug;36(3):274-81. doi: 10.1111/j.1365-2036.2012.05154.x. Epub 2012 May 30.

3.

Letter: TPMT - not all that glitters is gold.

González-Lama Y, Gisbert JP.

Aliment Pharmacol Ther. 2012 Jul;36(2):208-9; author reply 209-10. doi: 10.1111/j.1365-2036.2012.05148.x. No abstract available.

4.

Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease.

Herrlinger KR, Fellermann K, Fischer C, Kreisel W, Deibert P, Schoelmerich J, Fleig WE, Ruhl A, Reinshagen M, Greinwald R, Stange EF, Schwab M.

Aliment Pharmacol Ther. 2004 Jun 15;19(12):1269-76.

5.

High TPMT enzyme activity does not explain drug resistance due to preferential 6-methylmercaptopurine production in patients on thiopurine treatment.

van Egmond R, Chin P, Zhang M, Sies CW, Barclay ML.

Aliment Pharmacol Ther. 2012 May;35(10):1181-9. doi: 10.1111/j.1365-2036.2012.05084.x. Epub 2012 Apr 4.

6.

On the limitation of 6-tioguaninenucleotide monitoring during tioguanine treatment.

de Boer NK, de Graaf P, Wilhelm AJ, Mulder CJ, van Bodegraven AA.

Aliment Pharmacol Ther. 2005 Sep 1;22(5):447-51.

7.

The thiopurines: an update.

Coulthard S, Hogarth L.

Invest New Drugs. 2005 Dec;23(6):523-32. Review.

PMID:
16267626
9.

Extended thiopurine metabolite assessment during 6-thioguanine therapy for immunomodulation in Crohn's disease.

de Boer NK, Derijks LJ, Keizer-Garritsen JJ, Lambooy LH, Ruitenbeek W, Hooymans PM, van Bodegraven AA, de Jong DJ.

J Clin Pharmacol. 2007 Feb;47(2):187-91.

PMID:
17244769
11.

Optimization of azathioprine therapy by measuring 6-thioguanine nucleotides and methylated mercaptopurine in renal allograft recipients.

Bergan S, Rugstad HE, Bentdal O, Sødal G, Hartmann A, Klemetsdal B, Aarbakke J, Stokke O.

Transplant Proc. 1995 Dec;27(6):3426. No abstract available.

PMID:
8540033
12.
13.

Remission maintenance by tioguanine in chronic active Crohn's disease.

Herrlinger KR, Deibert P, Schwab M, Kreisel W, Fischer C, Fellermann K, Stange EF.

Aliment Pharmacol Ther. 2003 Jun 15;17(12):1459-64.

14.
15.

Thioguanine pharmacokinetics in induction therapy of children with acute myeloid leukemia.

Palle J, Frost BM, Petersson C, Hasle H, Hellebostad M, Kanerva J, Schmiegelow K, Lönnerholm G; Nordic Society for Paediatric Haematology and Oncology.

Anticancer Drugs. 2009 Jan;20(1):7-14. doi: 10.1097/CAD.0b013e32831bc086. Erratum in: Anticancer Drugs. 2010 Jan;21(1):130. Josefine, Palle [corrected to Palle, Josefine]; Britt-Marie, Frost [corrected to Frost, Britt-Marie]; Curt, Petersson [corrected to Petersson, Curt]; Henrik, Hasle [corrected to Hasle, Henrik]; Marit, Hellebostad [corrected to Hellebostad, Marit]; Jukka, Kanerva [corrected to Kanerva, Jukka]; Kjeld, Schmiegelow [corrected to Schmiegelow, Kjeld]; Gudmar, Lönnerholm [corrected to Lönnerholm, Gudmar].

PMID:
19342996
16.

A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis.

Teml A, Schwab M, Harrer M, Miehsler W, Schaeffeler E, Dejaco C, Mantl M, Schneider B, Vogelsang H, Reinisch W.

Scand J Gastroenterol. 2005 Oct;40(10):1205-13.

PMID:
16265777
17.

Monitoring 6-thioguanine nucleotide concentrations in Japanese children and adolescents with inflammatory bowel disease.

Ohtsuka Y, Arai K, Aoyagi Y, Fujii T, Yamakawa Y, Ohtani K, Ikuse T, Baba Y, Inage E, Kudo T, Suzuki R, Nagata S, Shimizu T.

J Gastroenterol Hepatol. 2010 Oct;25(10):1626-30. doi: 10.1111/j.1440-1746.2010.06364.x.

PMID:
20880170
18.

Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.

Kwan LY, Devlin SM, Mirocha JM, Papadakis KA.

Dig Liver Dis. 2008 Jun;40(6):425-32. doi: 10.1016/j.dld.2008.01.003. Epub 2008 Mar 4.

PMID:
18304898
20.

Azathioprine pharmacogenetics: the relationship between 6-thioguanine nucleotides and thiopurine methyltransferase in patients after heart and kidney transplantation.

Schütz E, Gummert J, Armstrong VW, Mohr FW, Oellerich M.

Eur J Clin Chem Clin Biochem. 1996 Mar;34(3):199-205.

PMID:
8721407

Supplemental Content

Support Center